Literature DB >> 19122921

Risk factors for mortality in patients with Acinetobacter baumannii bloodstream infection with genotypic species identification.

Dung-Hung Chiang1, Chien-Chun Wang, Han-Yueh Kuo, Hsin-Pai Chen, Te-Li Chen, Fu-Der Wang, Wen-Long Cho, Cheng-Yi Liu.   

Abstract

BACKGROUND AND
PURPOSE: Acinetobacter baumannii is an increasingly common nosocomial infection with a high mortality rate. Identification of predictor factors of mortality from A. baumannii infection is important for the implementation of therapeutic management for patients with higher risk. However, many studies have reported data for Acinetobacter calcoaceticus-A. baumannii complex, which might lead to an uncertainty of results. In this study, we aimed to identify the predictive factors for mortality of patients infected with true A. baumannii that had been precisely identified by genotypic methodology.
METHODS: Sixty seven patients with documented A. baumannii bacteremia were identified from a medical center in northern Taiwan during the period between February 1998 and February 2001. The patients' medical records were retrospectively reviewed.
RESULTS: The risk factors associated with mortality in patients with A. baumannii bacteremia were underlying disease with malignancy, end-stage renal disease, and inappropriate antibiotic therapy. Laboratory variables, such as creatinine level, were also associated with poor prognosis by multivariate analysis.
CONCLUSIONS: Increased serum creatinine level, malignancy and inappropriate therapy within 3 days were related to increased mortality in patients with A. baumannii bloodstream infection. Physicians should be aware of patients with poor prognostic factors and initiate prompt strategies, including appropriate antimicrobial therapy, in order to reduce mortality.

Entities:  

Mesh:

Year:  2008        PMID: 19122921

Source DB:  PubMed          Journal:  J Microbiol Immunol Infect        ISSN: 1684-1182            Impact factor:   4.399


  5 in total

1.  Clinical characteristics and outcomes of bacteremia due to different genomic species of Acinetobacter baumannii complex in patients with solid tumors.

Authors:  M-C Chiang; S-C Kuo; S-J Chen; S-P Yang; Y-T Lee; T-L Chen; C-P Fung
Journal:  Infection       Date:  2011-09-02       Impact factor: 3.553

2.  Identification of Ata, a multifunctional trimeric autotransporter of Acinetobacter baumannii.

Authors:  Leticia V Bentancor; Ana Camacho-Peiro; Cagla Bozkurt-Guzel; Gerald B Pier; Tomás Maira-Litrán
Journal:  J Bacteriol       Date:  2012-05-18       Impact factor: 3.490

3.  Risk factors and antibiotic resistance of pneumonia caused by multidrug resistant Acinetobacter baumannii in pediatric intensive care unit.

Authors:  Xiao-Fang Cai; Ji-Min Sun; Lian-Sheng Bao; Wen-Bin Li
Journal:  World J Emerg Med       Date:  2012

4.  The influence of carbapenem resistance on mortality in solid organ transplant recipients with Acinetobacter baumannii infection.

Authors:  Erika Ferraz de Gouvêa; Ianick Souto Martins; Marcia Halpern; Adriana Lúcia Pires Ferreira; Samanta Teixeira Basto; Renato Torres Gonçalves; Beatriz Meurer Moreira; Guilherme Santoro-Lopes
Journal:  BMC Infect Dis       Date:  2012-12-13       Impact factor: 3.090

5.  Active and passive immunization protects against lethal, extreme drug resistant-Acinetobacter baumannii infection.

Authors:  Guanpingshen Luo; Lin Lin; Ashraf S Ibrahim; Beverlie Baquir; Paul Pantapalangkoor; Robert A Bonomo; Yohei Doi; Mark D Adams; Thomas A Russo; Brad Spellberg
Journal:  PLoS One       Date:  2012-01-10       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.